Anderson in Genetic Engineering and Biotechnology News

Synthetic Biology Delivers Cool Tools but New Therapeutics Are a Ways Off

October 17, 2011 –

What does it take to transform a microbe normally found in the intestinal tract into a cancer-killing machine? These and other questions about the applicability of synthetic biology abound…. SBI’s J. Christopher Anderson, assistant professor of bioengineering at Berkeley, is developing bacteria as cancer-killing therapeutics.

He doesn’t disagree that the practical realization of these cancer bomb bacteria may be a ways off. “We have, thus far, made four fully functional devices. This is definitely a project at the leading edge of what you can do with genetic engineering tools today.”

Learn more at Genetic Engineering and Biotechnology News